Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Wins $12M Venture Financing

Premium

RESEARCH TRIANGLE PARK, NC--Paradigm Genetics, founded here in September 1997 by four former Novartis Crop Protection managers, closed its first round of financing with a $6 million preferred-stock equity offering and $6 million in venture lease financing. The agricultural biotechnology company said it will develop new products and pursue collaborations with major agriculture and chemical companies. Investors included Intersouth Partners of Durham, NC; Polaris Venture Partners of Boston; and the Innotech Investments, based in the UK.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.